DANA WYATT: Open Payments
NPI 1407215692 · CYNTHIANA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 31 payments from 15 companies in 2025. Trend: 2023 $261 · 2024 $198 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $156 |
| Axsome Therapeutics, Inc. | 3 | $85 |
| Dexcom, Inc. | 2 | $53 |
| Lilly USA, LLC | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Alkermes, Inc. | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Novo Nordisk Inc | 2 | $29 |
| Gilead Sciences, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $23 |
Products named: Kerendia, Auvelity, Dexcom G6 Transmitter, MOUNJARO, XIFAXAN, VIVITROL, TRINTELLIX, OTEZLA.
Industry payments across KY — which companies pay providers there.
